Iron-deficiency Anemia Market - Industry Outlook by 2025


Presentation Description

Iron-deficiency anemia can be diagnosed through medical history and blood tests. Blood tests typically include complete blood count (CBC). Other tests evaluate the level of iron, serum ferritin, and total iron binding capacity or transferrin.


Presentation Transcript

slide 1:

Iron-defciency Anemia Market - Global Industry Analysis Size Share Growth Trends and Forecast 2017 - 2025 Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Iron-deficiency Anemia Market". This report likewise incorporates more illumination about fundamental review of the business including definitions requisitions and worldwide business sector industry structure. Iron-deficiency anemia is a common type of anemia when the body does not have enough iron. Anemia is a medical condition caused due to low healthy red blood cells. RBCs red blood cells provide oxygen to body tissues. Iron plays a major role in making hemoglobin which is part of red blood cells. Lack of hemoglobin indicates less oxygen in the body. Hence it is quite important to maintain iron levels. The human body needs iron for oxygen transport Cellular respiration. Prevention is better than cure. Iron-deficiency anemia can be prevented through consumption of iron rich foods such as meat vegetables fruits and grains. Vitamin C also helps to prevent iron-deficiency anemia. Exhaustion and tiredness dyspnoea headache rough and dry skin tachycardia neurocognitive dysfunction restless legs syndrome hemodynamic instability brittle nails or hair loss and

slide 2:

yellow sallow skin are the major symptoms of iron-deficiency anemia. There is no sign or symptoms in patients with mild to moderate iron-deficiency anemia. Browse Full Research Report on Iron-deficiency Anemia Market: market.html Iron-deficiency anemia can be diagnosed through medical history and blood tests. Blood tests typically include complete blood count CBC. Other tests evaluate the level of iron serum ferritin and total iron binding capacity or transferrin. Generally these tests show following results: low ferritin low serum iron FE high transferrin or total iron binding capacity low mean cellular volume MCV low hemoglobin Hg and hematocrit Hct and low iron saturation. Pregnancy complication growth issue in children and infants are major complication of iron deficiency anemia. According to National Heart Lung and Blood Institute NHLBI report an estimated 20 women of childbearing age have iron-deficiency anemia. Rapid or irregular heartbeat due to low amount oxygen blood leads to major complications such as heart failure or an enlarged heart. Increasing the risk of haemodilution in pregnancy drive the iron- deficiency anemia market. Changes in lifestyle are playing a major role in propelling the global iron-deficiency anemia

slide 3:

market. High cost and lack of awareness are key restraints of the market. The iron-deficiency anemia market can be segmented based on therapy end-user and region. In terms of therapy the market can be categorized into dietary therapy oral iron therapy parenteral iron therapy and red cell transfusion. In terms of end-user the iron-deficiency anemia market can be segmented into hospitals ambulatory surgical centers and home health care. In terms of revenue the hospitals segment held a significant share of the iron deficiency anemia market. In terms of region the global iron-deficiency anemia market can be segmented into North America Latin America Europe Asia Pacific and Middle East Africa. North America is the largest market for iron-deficiency anemia followed by Europe and Asia Pacific. The U.S. is a major contributor to the iron deficiency anemia market in North America in terms of revenue. The market in Asia Pacific is expanding rapidly due to increase in number of patients. However Asia Pacific and Africa are projected to be the most attractive markets in the near future especially emerging economies such as such as Brazil India China and Japan due to its better health care infrastructure economic growth improving insurance payers expanding and

slide 4:

developing private health care sector and increasing awareness among people. Key players in the global iron-deficiency anemia market include Apotex Luitpold Pharmaceuticals Inc. AMAG Pharmaceuticals Acceleron Pharma Inc. Bayer AG Akebia Therapeutics Inc. Pharmacosmos A/S. About Us Transparency Market Research TMR is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts researchers and consultants use proprietary data sources and various tools and techniques to gather and analyze information. TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

slide 5:

Contact Us Transparency Market Research State Tower 90 State Street Suite 700 Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: Website:

authorStream Live Help